KRAS-Driven Selection of Molecular Therapy for Metastatic Colorectal Cancer: Choosing Between Bevacizumab, Cetuximab, Panitumomab, or a Combination
- Author
- Oncology Times
- Published
- Tue 21 Jul 2009
- Episode Link
- https://traffic.libsyn.com/secure/otbroadcastsarchives/090426JohnMacdonaldOTBN.mp3
